MergerLinks - Lindsey O'Crump

AcquisitionMajorityPrivateCross BorderPrivate Equity

target

FORBIUS

bidder

Bristol Myers Squibb Company

value n/a

49 dealmakers

Private EquityMajorityAcquisitionPrivateDomestic

Data Centers and Hosting

target

CLOSINGCORP

bidder

Stone Point Capital

value n/a

34 dealmakers

Japan

Payments / Commerce

Cross BorderPrivateAcquisitionMajority

target

PAIDY

bidder

Paypal Holdings

£1,950m

77 dealmakers

Customer Relationship Management

AcquisitionMajorityDomesticPrivatePrivate Equity

target

PRODEGE

bidder

Great Hill Partners

value n/a

18 dealmakers

PrivateAcquisitionMajorityDomestic

Software

target

BIODISCOVERY

bidder

Bionano Genomics

£74m

22 dealmakers

MajorityDomesticPrivateAcquisitionPrivate Equity

Software

target

POLLFISH

bidder

PRODEGE

value n/a

23 dealmakers

MajorityDomesticPrivateAcquisition

target

SUNOSI

bidder

Axsome Therapeutics

£40m

42 dealmakers

AcquisitionDomesticMergerPublicMajorityPrivatisation

Health Care Services

target

Turning Point Therapeutics

bidder

Bristol Myers Squibb Company

£3,270m

56 dealmakers

MajorityDomesticAcquisitionPrivate

target

VIACYTE

bidder

Vertex Pharmaceuticals

£265m

42 dealmakers

Germany

Information / Data Services

PrivateAcquisitionCross BorderMajority

target

BITBURST

bidder

PRODEGE

value n/a

19 dealmakers

PrivateMajorityAcquisitionDomestic

target

Redpin Therapeutics

bidder

Kriya Therapeutics

value n/a

15 dealmakers

Netherlands

Private EquityCross BorderAcquisitionMajorityPrivate

target

Neogene Therapeutics

bidder

Astrazeneca

£264m

60 dealmakers

MajorityAcquisitionCross BorderPublicPrivate Equity

target

Cincor Pharma

bidder

Astrazeneca

£1,487m

79 dealmakers

MajorityAcquisitionPrivateDomestic

target

Elicio Therapeutics

bidder

Angion Biomedica Corp

value n/a

30 dealmakers

AcquisitionDomesticPrivateMajority

IT Services: Other

target

TRANSPOSE

bidder

Chainalysis

value n/a

13 dealmakers

MajorityAcquisitionPrivateDomestic

target

Travere Therapeutics (bile Acid Product Portfolio)

bidder

Mirum Pharmaceuticals

£366m

32 dealmakers

AcquisitionDomesticPrivateMajority

target

Tentarix Biotherapeutics

bidder

Gilead Sciences

£52m

13 dealmakers

Cross BorderPrivateAcquisitionMajority

target

Propella Therapeutics

bidder

Astellas Pharma

£137m

41 dealmakers

France

Private EquityAcquisitionPrivateCross BorderMajority

target

Amolyt Pharma

bidder

ASTRAZENECA

£820m

60 dealmakers

DomesticMajorityPublicAcquisition

target

Landos Biopharma

bidder

Abbvie

£168m

39 dealmakers

United StatesUnited States